Arthritis in dogs and cats: the cat gap, the weight evidence, and what it costs in India

Signs of Osteoarthritis (arthritis) in dogs and cats

The 10 signs to watch for are listed below. Any one of them is a reason to consult your nearby vet; none of them is a diagnosis.

• Stiffness after rest or sleep that eases once the animal warms up
• Reluctance to jump onto a bed, a sofa or a windowsill
• Slower on stairs, or taking them one step at a time
• Limping that comes and goes, often worse the day after a long walk
• Less grooming, so the coat looks matted over the back and hips
• Missing the litter tray, or standing awkwardly in it
• Sleeping more, playing less, and hiding more than usual
• Flinching or snapping when touched over the hips, elbows or lower back
• Muscle loss over the hindquarters, so the back end looks narrower
• Nails growing long because the animal is walking less

Breeds on this site that document this condition

Each breed page below carries the figure for this condition with its denominator and its source. The 10 breeds listed are the ones on this site that document it, not a ranking of risk.

What arthritis in dogs and cats actually is, and the two numbers that disagree

Arthritis in dogs and cats is osteoarthritis, a joint disease in which joint fluid decreases and cartilage thins until the joint loses its shock absorption, bony change follows around the joint margin, and the animal is in pain. It is not only a senior disease and can develop at any age, especially where obesity or another orthopaedic condition is already loading the joint.

The two prevalence figures you will meet are 2.5 percent and 20 percent, and both of them are correct about different things. The largest study ever run on the question used the VetCompass programme to search the clinical records of 455,557 dogs under UK primary veterinary care during 2013, found 16,437 candidate cases, manually checked 6,104 of them and confirmed 4,196 against a written case definition, giving an annual period prevalence of diagnosed appendicular osteoarthritis of 2.5 percent (95 percent confidence interval 2.4 to 2.5), or roughly 200,000 affected UK dogs a year.

That 2.5 percent is not what the ranking pages print. VCA Animal Hospitals, opened on 27 September 2026, states that osteoarthritis affects at least 20 percent of dogs over one year old and 80 percent of dogs over eight years old, and names no study and no denominator for either number. The cat side is written the same way, and betterpet, ranking today on Google India for the feline query, states that between 60 and 80 percent of cats over the age of ten show signs of arthritis, again with no denominator and no study named. Anderson and colleagues recorded that same spread in the literature they were testing against, where published estimates ranged from 6.6 percent to 20 percent.

A 2025 review of feline osteoarthritis reconciles the two. Post-mortem evaluations, it reports, suggest an estimated clinical prevalence of 2.5 percent against a true prevalence of 20 percent. One number counts the animals a vet wrote down. The other counts the animals whose joints are actually damaged. Nothing on either Google India top ten today explains that, which is why an owner reading both leaves confused rather than informed.

The radiograph is not the disease, and it misses plenty

A radiograph under-reads joint damage, and the best evidence for that comes from the only cohort of dogs ever followed from weaning to death with their joints examined afterwards. Across 48 Labrador Retrievers, radiographic shoulder osteoarthritis was identified in 78 percent of dogs, gross examination found cartilage erosion on the caudal humeral head in 40 of 46 dogs, and by end of life 91 percent had histopathological changes consistent with osteoarthritis; the authors concluded that radiographic evaluation correlates poorly with the severity of shoulder joint pathology.

The reverse error happens too. The US Food and Drug Administration describes a study of 13 cats in which half the cats' joints had osteoarthritis but only 10 percent of joints were both painful on examination and changed on the X-ray. A painful joint and an abnormal film are two different findings in a cat, and treating either one as the test gets a large share of animals wrong.

What actually raises the odds

Age dominates every risk model. In the UK dog population, dogs over 12 years carried 53.89 times the odds of a diagnosis compared with dogs under three (95 percent confidence interval 44.57 to 65.15), and the median age at first diagnosis was 10.5 years against a median of 4.1 years in the population as a whole. In cats, each additional year of age raised the expected total degenerative joint disease score by an estimated 13.6 percent (95 percent confidence interval 10.6 to 16.8).

Size and weight come next, and they are the part an owner can change. The table below reports the odds ratios from the 455,557-dog study.

Read the bodyweight rows twice. A dog over 40 kg carried 11.28 times the odds of a dog under 10 kg, and a dog heavier than the mean for its own breed carried 2.29 times the odds of a lighter one of the same breed. Breed sets the first number and you cannot change it. The second number is the feeding bowl.

One risk factor in that model is not a risk factor at all. Insured dogs carried 1.86 times the odds of a diagnosis, and the authors attribute that to the cost of imaging being removed rather than to insurance causing arthritis. That is a detection effect, and it is worth holding on to, because India is a country where almost nobody insures a pet and the diagnostic bar is therefore higher still.

Osteoarthritis is usually the end point of something else. On this site, hip dysplasia in dogs, elbow dysplasia in dogs, luxating patella in dogs and cruciate ligament rupture in dogs each have their own page, and each of them ends in the joint disease described here. Obesity in dogs and cats is the fifth, and unlike the other four it is not inherited.

The cat gap, from 1 percent on the record to 39 percent on a checklist

Feline osteoarthritis is close to silent, and one 2025 study measured how silent with two denominators in the same five clinics. Reviewing 502 cat medical records using the historical methods of oral history and physical examination, 1 percent had orthopaedic-related issues. Handing a one-page checklist to the owners of the next 437 cats through the door, 39 percent showed at least one behaviour consistent with osteoarthritis.

The comparison gets starker with age. Among cats over 12 years, the record review found chronic osteoarthritis in 5 percent of 66 cats, while the checklist flagged 71 percent of 80 cats in the same age band. Among cats under six, the record review found 0 percent of 348 and the checklist found 9 percent of 208.

The radiographic surveys are what corroborate it, and they have been saying the same thing for over twenty years without changing clinical practice much. Every one of them is small, and every one of them carries its denominator.

Pooling everything published to date, a 2025 review calculates that 25.6 percent of cats, 454 of 1,772 aged 0.2 to 20.0 years, showed radiographic evidence of osteoarthritis in at least one appendicular joint, across studies whose individual results ranged from 16 to 91 percent. That spread is not noise. It is the difference between screening every joint in a sedated cat and reading whatever films happened to be taken.

The Tokyo study contains the whole problem in one sentence. Of 101 cats, 74.26 percent had radiographic appendicular degenerative joint disease, lameness was recognised by the owners of two cats, and no obvious pain was detected on palpation in any cat with appendicular osteoarthritis. Seventy-five affected cats, two owners who noticed, and a physical examination that found nothing.

One cat breed turns this from a probability into a certainty, and Indian buyers meet it often. In a three-generation pedigree in which folded-eared cats were mated to normal-eared cats, every cat with folded ears developed osteochondrodysplasia in the distal fore and hind limbs, with severity differing in each animal and the mildest cases showing no clinical signs at all.

A later study removed the obvious objections to that finding. Twenty-two Scottish Fold cats were genotyped and radiographed, all ten folded-eared cats carried one copy of the TRPV4 variant and none of the twelve straight-eared cats carried it, and four reviewers scored the films blinded to ear phenotype. Against that background, a clinical diagnosis rate of 12 in 1,131 Australian Scottish Folds is not reassurance, it is the size of the recording gap in the one population where we know what the true rate is. The Scottish Fold breed page works through the genetics and the Indian price of that decision.

Why cats hide it and dogs do not

A dog with a sore hip limps on a walk you take it on. A cat sets its own schedule, and the first thing it drops is the behaviour you were not measuring. The signs the FDA lists for cats are weight loss, loss of appetite, reduced activity, a change in attitude towards grumpier or quieter, and reduced grooming, none of which looks like lameness. International Cat Care adds difficulty using the litter tray with accidents outside it, and difficulty getting through a cat flap.

Owner-reported mobility change is common enough to measure. In the Bristol Cats longitudinal cohort, 238 of 799 cats, 29.8 percent, had owner-reported mobility changes at six years of age. Six years old is not old.

The six activities that screen a cat, and what to watch in a dog

To screen a cat for arthritis at home, watch six activities over one week and note any your cat now finds difficult. The validated checklist uses climbing up stairs, climbing down stairs, chasing moving objects, jumping up, jumping down and running, and it carries 97 percent specificity for degenerative joint disease, so a positive answer to any single question rarely turns out to be a false alarm.

Run it properly and it takes a week of noticing rather than an appointment. The four steps are set out below.

1. Pick a week and watch, do not test. The checklist asks owners to consider the cat's activities in the past week and tick what they observed, not to make the cat perform.
2. Score the six activities separately. Climbing up stairs and climbing down stairs are two different questions, and a cat often loses one before the other.
3. Compare against your own cat a year ago, not against a textbook cat. Mobility scoring in the Bristol Cats cohort worked because owners answered about their own animal over time.
4. Take a positive answer to the vet rather than to the internet. With 97 percent specificity the tool rarely generates a false positive, which means a tick is worth an appointment.

Dogs give you more to work with, because you walk them. The signs list on this page is the one to scan, and the pattern that matters most is stiffness that is worst after rest and eases with movement, which is the opposite of an injury. Cornell describes the underlying process as progressive cartilage deterioration with bony change and inflammation building around the joint.

What gait analysis could not do

Do not expect a walk past the vet to settle it in a cat. Fifty-three UK cats aged seven to ten walked over a pressure-sensitive walkway after an orthopaedic examination; 22 of them, 42 percent, had findings consistent with musculoskeletal disease, and 13 of those 22 had more than one limb involved. A linear mixed-effects model found no significant difference in any spatiotemporal or kinetic gait variable between the affected and the apparently healthy cats, and paw pressure asymmetry did not separate them either.

The same study found the thing an owner can act on. Cats with musculoskeletal disease were heavier, at a mean 5.4 kg against 4.7 kg (P = 0.048), and carried a higher body condition score, median 6 against median 5 (P = 0.015).

How arthritis is diagnosed, and what the films cost in India

Arthritis is diagnosed on the combination of what the owner reports, what the vet finds on joint palpation and range of motion, and what radiographs show, and no one of those three settles it alone. In India the radiograph is the cheap part of that list, priced at Rs 100 to Rs 400 across three government veterinary hospitals.

Three Indian state and central veterinary teaching hospitals publish their own rate cards, and all three price a plain film for a dog or cat under Rs 500.

Every figure in that table is in rupees on an Indian government page and none of them is a converted dollar list. The IVRI charges are in force from July 2022 and are quoted plus tax as applicable. Madras Veterinary College, which sits under Tamil Nadu Veterinary and Animal Sciences University, adds a detail no private clinic matches, because its pharmacy operates on an annual budget of Rs 25,00,000 from which drugs and fluids are dispensed free of cost for animals brought to the hospital.

The single most useful line on any of those cards for an arthritic animal is the IVRI entry pricing physiotherapy and acupuncture at Rs 100. Rehabilitation is the part of arthritis care that Indian owners are usually told does not exist here, and one central government institute prints a price for it.

What to bring, because the history is half the diagnosis

The consultation is worth more if you arrive with observations rather than adjectives. Take the list below.

• A filled-in six-activity checklist for a cat, covering climbing up stairs, climbing down stairs, chasing moving objects, jumping up, jumping down and running.
• A phone video of the animal rising from lying down, taken cold, first thing in the morning, because stiffness after rest is the sign that separates this from an injury.
• An honest current weight and a body condition score, since weight is both a risk factor and the treatment with the best evidence. Expect the vet to record a pain score at this visit and to repeat the same pain score later, because a single reading tells nobody whether treatment is working.
• A date for when you first noticed the change, because median age at first diagnosis in UK primary care was 10.5 years while the median dog in that population was 4.1 years old, and late diagnosis is the norm rather than the exception.

Expect the vet to look beyond the obvious joint. In cats the commonest sites are the hip, stifle, tarsus and elbow in that order, and the thoracic spine is affected more often than the lumbosacral segment. In dogs the diagnosis in primary care is of appendicular disease, meaning the limbs rather than the spine.

Treatment in general terms, and what each part is actually for

Treatment for arthritis in dogs and cats has one honest goal, which is to control pain and protect what movement remains, because there is no cure for osteoarthritis in either species. A plan is built from weight control, pain relief, controlled exercise and changes to the home, and your nearby vet decides which parts apply to your animal, in what order, and what to prescribe.

Nine in ten diagnosed dogs get some clinical management, since 90 percent of confirmed cases in the UK primary-care study had management implemented. What follows describes the categories in general terms. This page names no dose for anything, because dosing is a decision for the veterinarian looking at your animal.

Pain relief

Non-steroidal anti-inflammatory drugs are the first-line class in dogs, and several are approved for long-term use to control the pain and inflammation of canine osteoarthritis. In cats the position is entirely different and it has its own section below. Newer classes sit alongside the older ones. A randomised, double-blind non-inferiority trial in 32 dogs over 20 kg with hip or stifle osteoarthritis compared a monthly anti-nerve growth factor injection against a daily oral prostaglandin-receptor antagonist using force-plate gait analysis, and found treatment success at day 42 of 68.8 percent against 56.3 percent, a difference of 12.5 percent whose confidence bound fell inside the pre-specified non-inferiority margin.

That trial's conclusion is the useful part for an owner. Both treatments were judged appropriate first-line options, which means there is no single best drug and the choice is a clinical one about your animal's kidneys, liver, stomach and budget.

Joint supplements

Joint supplements are the category with the most marketing, and on the question most of them are sold to answer the evidence is not divided. A systematic review and meta-analysis registered on PROSPERO in advance covered 72 trials from 57 articles across nine categories of natural health compound, and the chondroitin-glucosamine category returned 88.9 percent non-effect and 0 percent effect across its nine trials, with an effect size of d = -1.39, meaning the comparison favoured the control group rather than the product. Its abstract reports 'a very marked non-effect of chondroitin-glucosamine nutraceuticals' and recommends that 'the latter products should no longer be recommended for pain management in canine and feline osteoarthritis';. The same review found the opposite for omega-3, at d = 1.19 for omega-3 nutraceuticals and d = 0.58 for omega-3-enriched therapeutic diets, both favouring the product. One scope point belongs with all of that: every one of those 72 trials was run in animals that already had osteoarthritis and measured pain, so none of them tested prevention in a healthy animal, which is the question most buyers are asking at the counter; our guide to supplements for dogs and cats in India carries that in full. The 2025 feline review is blunt that most alternatives to anti-inflammatory drugs in cats rest on human studies and on veterinary research in other species, which introduces a high risk of bias. Where Indian evidence exists at all it is small and sponsor-funded, and it is described in the India section below.

Exercise and physiotherapy

Controlled exercise keeps muscle on the limb, and rehabilitation is a real category rather than a luxury. ICAR-IVRI prices physiotherapy and acupuncture on its published fee card, and Madras Veterinary College runs a named orthopaedics referral unit alongside radiology and computed tomography. Both are government institutions, so this is not a metropolitan private-clinic service only.

Prognosis

Arthritis is a long condition rather than a fatal one. In UK primary care the median time from first diagnosis to death was 3.0 years with an interquartile range of 2.0 years, and the disease occupied a median 11.4 percent of affected dogs' lifespans (95 percent confidence interval 10.0 to 12.9, based on 384 dogs with both dates recorded). A dog diagnosed at ten is not a dog at the end of its life, and the question is what those years feel like.

Weight control, the intervention with the best evidence and no prescription

Weight control has the strongest evidence of any arthritis intervention in dogs, and the strongest single result comes from a lifelong randomised feeding study. Across 48 Labrador Retrievers paired by litter, sex and weight, the median age at first radiographic hip osteoarthritis was 6 years in the freely fed group against 12 years in the group fed 25 percent less of the same food.

That study is worth understanding in detail, because nothing else in veterinary orthopaedics is built like it. Forty-eight six-week-old puppies from seven litters were paired with littermates by sex and weight, each pairmate was randomly assigned to one of two groups of 24, and from eight weeks of age one group was fed freely while the other was fed 25 percent less of the same diet for life on a pairwise basis; a board-certified radiologist who did not know the group assignments scored the films. Across all the dogs, hip osteoarthritis rose from 15 percent at two years to 67 percent by 14 years.

The same cohort showed the effect at a second joint. Radiographic shoulder osteoarthritis severity was significantly lower in the diet-restricted dogs at six years (P less than 0.03) and at eight years (P less than 0.02).

A second, earlier trial agrees closely. Nine client-owned dogs with radiographic hip osteoarthritis, each 11 to 12 percent above ideal body weight, lost between 11 and 18 percent of their initial body weight on a restricted-calorie diet, and body weight, body condition score and severity of hind-limb lameness all decreased significantly. Two independent groups, 14 dogs and 9 dogs, both finding that weight reduction alone improves lameness.

The cat column is empty, and that is the finding

The last row is not a formatting error. The 2025 review ran a structured database search for food restriction and weight loss in feline osteoarthritis across PubMed and Google Scholar and recorded zero articles, and states plainly that no prospective study of the effect of exercise and weight loss on osteoarthritis has yet been conducted in cats. Every page that tells you to slim an arthritic cat, including this one, is reasoning across from dogs and from humans.

The indirect evidence in cats is still worth having. Among 1,457 cats from 27 veterinary hospitals followed for 4.5 years, heavy cats were 2.9 times as likely to be taken to a vet for lameness unrelated to bite abscesses, and obese cats were 4.9 times as likely to develop lameness requiring veterinary care. In the Bristol Cats cohort, being overweight or obese at six years carried an odds ratio of 1.62 for owner-reported mobility change (95 percent confidence interval 1.13 to 2.33).

Three other things predicted mobility change in that cohort, and two of them describe ordinary Indian cat-keeping. Being entire at six months of age carried an odds ratio of 1.97 (95 percent confidence interval 1.26 to 3.07), having sustained trauma before six years carried 1.85 (1.30 to 2.60), and outdoor access at six years carried 1.67 (0.96 to 2.90). A free-roaming, unneutered Indian cat collects all three.

If your animal is overweight, start there and read the obesity page next, then the dog diet chart for India or the cat diet chart for India for the grams. Weight management is the one part of this you control without a prescription, and your vet should set the target.

The species difference that can kill a cat, and the two regulators that disagree

A cat is not a small dog where pain relief is concerned, and the difference is lethal at the extreme. Acetaminophen, which veterinarians will sometimes use in dogs, is fatal to cats, because cats lack certain enzymes the liver needs to break the drug down safely. Nothing from a human medicine cabinet goes into either animal without a veterinarian saying so.

The species split runs through the whole drug class, not just one molecule. When the US Food and Drug Administration describes non-steroidal anti-inflammatory side effects, it notes that cats are more likely to suffer red blood cell damage while dogs are more likely to get liver damage. That is a metabolic difference between two species, not a dosing difference between two sizes of animal.

Two regulators, two answers, both current

Here the sources disagree, and an Indian reader deserves both rather than whichever is more convenient. In the United States, only two non-steroidal anti-inflammatory drugs are approved for cats at all, meloxicam as a single pre-surgical injection and robenacoxib for no more than three days, and the FDA states flatly that no such drug is currently approved for long-term use in cats. Its osteoarthritis page repeats the point, that no veterinary anti-inflammatory is approved for safe, long-term control of feline osteoarthritis pain.

In the United Kingdom the same molecule is licensed for exactly that. The Summary of Product Characteristics for Metacam oral suspension for cats, approval number 01195/2025 with amended pages dated April 2026, gives the indication as alleviation of pain and inflammation in acute and chronic musculo-skeletal disorders in cats, and its precautions section says that in chronic musculoskeletal disorders in cats the response to long-term therapy should be monitored at regular intervals by a veterinary surgeon. A regulator does not write a monitoring instruction for a therapy it forbids.

International Cat Care states the position neutrally, that several different non-steroidal anti-inflammatory drugs are licensed for use in cats in different countries. The published evidence leans towards the European reading. Two Australian feline-only clinics reviewed cats over seven treated continuously with oral meloxicam for longer than six months and found a median longevity of 18.6 years in the group with chronic kidney disease (95 percent confidence interval 17.5 to 19.2) and 22 years in the group without (95 percent confidence interval 18.5 to 23.8), concluding that long-term treatment did not appear to reduce the lifespan of cats with pre-existing stable kidney disease.

That is a retrospective study of cats a clinician chose to treat, not a randomised trial, and it cannot rule out that the healthier cats were the ones put on the drug. It is still the largest published look at the question, and it points the other way from the American label. Your vet resolves that disagreement for your cat, with its kidney values in front of them.

Monoclonal antibodies against nerve growth factor, and whether India has them

Two species-specific monoclonal antibodies against nerve growth factor now exist for osteoarthritis pain, bedinvetmab for dogs and frunevetmab for cats, both given as a monthly injection. On 27 September 2026, neither appears on Zoetis India's own canine product page, which lists eight products and none of them for pain.

Take the evidence first, because the question of whether to want the drug comes before the question of whether you can get it. The pivotal feline trial was a randomised, placebo-controlled, parallel-group, double-blind superiority study in 275 client-owned cats with naturally occurring osteoarthritis pain, dosed on days 0, 28 and 56 and assessed by owner questionnaire and veterinary examination. It beat placebo, and the trial reports its effect size honestly rather than as a marketing claim.

In dogs the comparison that matters is against the drugs we already had. The 32-dog force-plate trial found the monthly antibody non-inferior to a daily oral tablet, with treatment success of 68.8 percent against 56.3 percent at day 42, and concluded that both are appropriate first-line treatments. That is a real option, not a replacement for everything else.

The Indian availability check, and how it was run

The honest answer is that this page could not confirm either product is on sale in India, and the test used was a positive one rather than a shrug. Zoetis India's own Products and Solutions page for dogs was opened on 27 September 2026 and lists its canine portfolio under four headings, anti-infective, parasiticides, nutritional products and vaccines, naming eight products in total: Convenia, Simparica, Revolution, Pet-Tabs, Defensor, Vanguard Plus 5L4, Vanguard Plus 5CVL and Vanguard Plus 5CVL4. The word Librela does not appear on it, there is no pain management heading, and the page's own footer states that the product information is intended only for residents of India and that products may carry different labelling in different countries.

One more caution belongs on any page that mentions these drugs. The 2025 feline review calls them a promising new avenue while stating that the long-term effects of repeated administration, the optimal conditions for administration and the specific indications have yet to be described. A drug licensed in 2021 has not yet been given to a cat for a decade, and nobody can tell you what a decade of it does.

The home setup, and the honest evidence behind the rug advice

Every arthritis page tells Indian owners to put rugs on the floor, and the advice is cheap, harmless and worth taking. It is also weaker than it sounds. In ten healthy dogs walked over linoleum and over carpet under tightly controlled speed, there was no significant difference in any ground reaction force measured.

Read that result precisely, because it says something narrower than it first appears. Kapatkin and colleagues tested normal dogs, not arthritic ones, and they measured the forces going through the limb, not the animal's confidence in placing it. The finding is that a hard smooth floor does not load a sound joint harder than carpet does. It is not a finding that slipping does not matter.

The one controlled test of a traction aid in dogs went the same way. Thirty dogs were followed for two weeks after a tibial plateau levelling osteotomy, 13 wearing nail grips and 17 wearing sham grips, scored by blinded observers, and there were no differences in visual lameness score or total pressure index at any time point; the client-specific measure that asked specifically about walking on slippery flooring also showed no difference, at P = 0.78. The grips were well tolerated and the study did not demonstrate a benefit.

The changes that specialist bodies actually recommend

The home modifications below come from International Cat Care and the FDA, and most of them transfer to a dog with the obvious substitutions.

• Put a litter tray indoors with at least one low side, and use a soft, sandy litter that is comfortable to stand on.
• Remove the jump from everything that matters. Provide steps or a ramp to reach the sofa, the windowsill or the bed, and make sure food, water and the tray need no stairs at all.
• Raise the food and water bowls so the animal is not bending down to eat.
• Provide soft bedding in a quiet, draught-free place.
• Groom the animal yourself and trim the claws, because a stiff cat stops grooming and stops wearing its nails down, and both problems compound.

The Indian version of the bedding problem is specific and it is worth naming. In a Chennai or Ahmedabad flat in May, the coolest surface in the house is bare stone or tile, which is exactly where an animal will choose to lie and exactly the hardest surface available, while the soft options are the hottest and usually require a jump. The Scottish Fold page works through that trade-off in detail for cats. The practical answer is to give the animal a cool, soft option at floor level rather than making it choose between temperature and comfort.

What an Indian owner can actually do, and what the Indian evidence amounts to

India has published no prevalence figure for osteoarthritis in dogs or cats, and the entire Indian canine osteoarthritis literature amounts to two small sponsor-funded supplement trials of 26 dogs and 20 dogs, plus review papers. What India does have is cheap radiographs, cheap physiotherapy on one government card, and a pain drug sold over a mainstream pharmacy counter for under a hundred rupees.

Take the absence first, because it was tested rather than assumed. Searching Europe PMC on 27 September 2026 for osteoarthritis in dogs with India in the title or abstract returned four records, and all four are artefacts of the phrase India ink, the carbon stain used to mark cartilage lesions; they are studies from the University of Missouri and from the Federal University of Rio Grande do Sul in Brazil. The roster this page was built from recorded three such records and they fail the same way.

The affiliation search is the instrument that works. Searching the same index for osteoarthritis in dogs with an Indian author affiliation returned five records, of which three are reviews from ICAR-IVRI Izatnagar on platelet-rich plasma and cell-free therapy, and two are clinical trials. Both searches were run in the same session as a Labrador control that returned 110 on-topic papers with the correct field syntax against three unrelated haematology abstract books with PubMed syntax, so the counts above come from a working instrument.

The two Indian trials, described honestly

The first enrolled 26 client-owned dogs with moderate osteoarthritis in a randomised, double-blind, placebo-controlled pilot, of which 23 completed the 30-day trial, a completion rate of 88.5 percent; the dogs had a mean age of 6.52 years and a mean body weight of 37.88 kg, and the enrolled breeds included six Labrador Retrievers, four German Shepherds, two Great Danes and a Rottweiler. Lameness scores fell by 51.96 percent in the treatment group against placebo. The authors are at PRADO Pune, COVAS Parbhani, Animedics Health India in Pune and the Andhra Pradesh Med Tech Zone Animal Research Centre in Visakhapatnam, and the test article was supplied by its American manufacturer.

The second randomised 20 dogs into two groups of ten at Mumbai Veterinary College under Maharashtra Animal and Fishery Sciences University, comparing a turmeric extract against a marketed glucosamine and chondroitin product over 42 days, with 18 dogs in the final analysis; the sponsor was the company in Bengaluru, Karnataka that makes the extract. Radiographs were taken on day 0 and day 42 and read by radiologists at the veterinary hospital.

Neither is a prevalence study, both are small, and both were paid for by the maker of the product being tested. They are worth naming anyway, because they are what exists, and because an Indian owner offered a joint supplement deserves to know the size of the evidence base behind the category in this country.

The pharmacy counter problem

The India-specific hazard on this condition is not access, it is ease of access. Melonex Pet Oral Suspension, a 10 ml bottle of meloxicam marketed by Intas Pharmaceuticals, is listed on Tata 1mg at a maximum retail price of Rs 84 and a selling price of Rs 76.1, on Netmeds at a maximum retail price of Rs 82, and on Supertails at Rs 76. All three flag that a prescription is required Netmeds, Intas Melonex Oral Susp Vet 10 ml.….

Divide Rs 84 by 84.38 and you get one US dollar; divide it by 74 and you get 1.14. This is a genuinely Indian price for a month of pain relief, not a converted foreign list, and that is exactly what makes it dangerous to self-medicate with.

The listings disagree with each other about the species. Tata 1mg describes the product as relieving pain and inflammation in dogs, naming osteoarthritis, musculoskeletal injuries and post-surgical recovery. Netmeds describes the same product as indicated for arthritis, musculoskeletal disorders and post-surgical pain in dogs and cats, then adds in its own text that use in cats should be done with extreme caution and only under strict veterinary supervision because cats are more sensitive to the medication.

Monsoon damp, and the placebo in your own head

Owners in monsoon India expect damp weather to make a stiff dog stiffer, and the one study that measured it did not find that. Sixty-two dogs with osteoarthritis wore accelerometers while their daily activity counts and the Canine Brief Pain Inventory scores filled in by their owners were compared against average, high and low temperature, relative humidity, total precipitation, barometric pressure and daylight hours. Relative humidity, total precipitation and barometric pressure showed no significant relationship with measured activity at all.

Average temperature and daylight hours did correlate, and the authors are careful about how much that is worth, because together they accounted for less than 1 percent of the variation in activity counts. A humid Mumbai July is not, on this evidence, the reason your dog is slower.

The same study found something more useful and more uncomfortable. Canine Brief Pain Inventory scores for pain severity and pain interference fell significantly over the test period with no treatment change to explain it, which the authors attribute to a caregiver placebo effect. Owners watching an arthritic dog report improvement over time because they are watching and hoping. That is the reason a vet repeats an objective measure rather than asking you again how the dog seems.

What India makes genuinely affordable is the diagnosis and the rehabilitation. A plain film costs Rs 100 at Madras Veterinary College, Rs 150 at ICAR-IVRI and Rs 400 at BASU Patna ICAR-Indian Veterinary Research Institute Bihar Animal Sciences University, Patna. Physiotherapy and acupuncture are priced at Rs 100 on the IVRI card. For an owner weighing whether to investigate a stiff old dog, the investigation costs less than a week of premium food.

Living with an arthritic dog or cat in an Indian home

Living with arthritis means managing a condition for years rather than fixing it, and the median dog in UK primary care lived 3.0 years after its first diagnosis. The daily work is weight, movement, footing and watching, and most of it costs nothing.

Set the weight target with your vet and then hold it, because that is the single intervention with a lifelong randomised trial behind it and the one where a six percent change showed up as less lameness within sixteen weeks. Everything else on the list supports it.

Keep the animal moving rather than resting it. Controlled exercise maintains the muscle that stabilises a bad joint, and rehabilitation is priced on an Indian government card rather than being a Western luxury. Ask specifically about physiotherapy if your nearby clinic does not raise it.

Re-screen the cat every few months rather than once. The six-activity checklist takes a week of watching, carries 97 percent specificity and works precisely because it asks about behaviour at home where cats show the signs, rather than in a consulting room where they do not.

Expect the diagnosis to arrive late and do not read that as your failure. The median age at first diagnosis in a population of 455,557 dogs was 10.5 years, against a median population age of 4.1 years, and in cats a record review found orthopaedic problems in 1 percent of animals that a checklist flagged at 39 percent. The whole profession diagnoses this condition late.

Two of this site's guides carry the routine that surrounds it. Senior dog care in India and senior cat care in India cover the age checks, the tests and the pain conversation in more detail than a condition page should.